Medicina de Família
Estudo de coorte | Em crianças com síndrome inflamatória multissistêmica (multisystem inflammatory syndrome – MIS-C) associada à Covid-19, não houve evidência de diferenças na recuperação após tratamento inicial com imunoglobulina intravenosa (IGIV) isolada, IGIV com glicocorticoides ou glicocorticoides isolados.
18 Jun, 2021 | 10:42hTreatment of Multisystem Inflammatory Syndrome in Children – New England Journal of Medicine
Editorial: Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
Comentários: Steroids may be effective treatment for COVID-19 complications in children – Imperial College London E Expert reaction to study looking at treatments for COVID-19 complications in children – Science Media Centre
Estudo de coorte | Em crianças com síndrome inflamatória multissistêmica (multisystem inflammatory syndrome – MIS-C) associada à Covid-19, o tratamento inicial com imunoglobulina intravenosa (IGIV) e glicocorticoides foi associado com menor risco de disfunção cardiovascular nova ou persistente em comparação ao tratamento com IGIV isolada.
18 Jun, 2021 | 10:40hEditorial: Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
Entrevista em áudio | Potenciais tratamentos para crianças com síndrome inflamatória multissistêmica (multisystem inflammatory syndrome – MIS-C) associada à Covid-19.
18 Jun, 2021 | 10:38hAudio Interview: Covid-19 in Children – New England Journal of Medicine
Dr. Fauci afirma que os riscos trazidos pela variante Delta acentuam a importância das vacinas.
18 Jun, 2021 | 10:38hDr. Fauci Says The Risks From The Delta Variant Underscore The Importance Of Vaccines – NPR
Opinião | Causalidade ou confusão: por que os grupos controle são fundamentais para caracterizar a “long COVID” – “Muitos dos sintomas autorrelatados, como cefaleias intermitentes ou cansaço, são inespecíficos e prevalentes na população geral.”
18 Jun, 2021 | 10:37hCausation or confounding: why controls are critical for characterizing long COVID – Nature
Estudo mostra que a taxa de reinfecção por COVID-19 é inferior a 1% em pacientes que tiveram doença grave.
18 Jun, 2021 | 10:35hEstudo original: Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing – Clinical Infectious Diseases
OMS | Taxas de partos cesarianos continuam a subir, em meio ao aumento nas desigualdades de acesso.
18 Jun, 2021 | 10:32hEstudo original: Trends and projections of caesarean section rates: global and regional estimates – BMJ Global Health
Comentário no Twitter (fio – clique para saber mais)
Caesarean section use continues to rise 📈 globally, now accounting for more than 1 in 5 of all childbirths.
C-section can put women and babies at unnecessary risk of short- and long-term health problems if performed when there is not medical need
— World Health Organization (WHO) (@WHO) June 17, 2021
M-A | Tratamentos agudos para enxaqueca episódica em adultos.
18 Jun, 2021 | 10:28hAcute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis – JAMA (gratuito por tempo limitado)
Editorial: Acute Treatment for Migraine: Contemporary Treatments and Future Directions (gratuito por tempo limitado)
Comentário no Twitter (fio – clique para saber mais)
Science marches breathlessly forward – or, at least tries to expand its indication.
Anti–calcitonin gene-related peptide antibody infusion, again, vs. placebo.
— Ryan Radecki, MD MS (@emlitofnote) June 17, 2021
Agora, o CDC chama a variante Delta do coronavírus de “variante de preocupação”.
17 Jun, 2021 | 11:02hCDC now calls coronavirus Delta variant a ‘variant of concern’ – CNN
Diretriz: SARS-CoV-2 Variant Classifications and Definitions – Centers for Disease Control and Prevention
Comentário no Twitter
BREAKING—CDC now officially declares #DeltaVariant a “variant of concern”—because much more transmissible (50% faster than #B117, 2x than original strain), more severe (2.5x hospitalization risk than B117, 4x original) & 1 dose vaccine evasive.🧵 #COVID19https://t.co/jZCgfzFLla pic.twitter.com/SszvXuysze
— Eric Feigl-Ding (@DrEricDing) June 15, 2021
Série de casos | 7 casos de miocardite após vacinação baseada em mRNA contra COVID-19.
17 Jun, 2021 | 11:00hMyocarditis after BNT162b2 and mRNA-1273 Vaccination – Circulation
Relacionado: CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare. E Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. E CDC is investigating several reports that teenagers and young adults may have developed myocarditis after receiving mRNA vaccines. Most cases were mild, more often in males than females, more often following dose 2 than dose 1, and typically, within 4 days after vaccination.